• Clean Energy Connect

  Participated · Debt Financing · Dec 2025

  Clean Energy Connect supports RE100 participants and other decarbonisation-focused companies with end-to-end green electricity solutions, covering planning, installation, verification and ongoing optimisation. Its core offering is the development and operation of Non-FIT off-site solar power plants that supply renewable electricity and environmental value through long-term corporate PPAs. The firm has already signed bespoke PPA contracts with Amazon, Dai-ichi Life, the NTT Group, Nomura Real Estate, Sugi Holdings, Fujifilm, Google, Mitsubishi Estate, Chiba University and others. Future initiatives include combining solar with battery storage, wind power and BEMS to raise 24/7 renewable energy utilisation rates. Headquartered in Otemachi, Tokyo, the company positions itself as a one-stop provider of cutting-edge decarbonisation solutions. As of the latest financing, Clean Energy Connect’s cumulative capital raised totals ¥611 billion.

• ThinkCyte

  Led · Series C · Aug 2024

  ThinkCyte develops VisionSort, the company’s flagship AI-based, dual-mode fluorescence and morphometric cell sorting platform, launched in June 2023. VisionSort has been adopted by major biopharmaceutical companies and leading academic research institutions worldwide. The company plans to use new funding to scale production and manufacturing and to accelerate global commercial expansion of VisionSort. ThinkCyte completed a Series C financing (including a recent extension) and also secured a loan to support growth. The new proceeds bring ThinkCyte’s total funding to $91 million. ThinkCyte was founded in 2016 and maintains offices in Tokyo, Japan and Redwood City, California. ThinkCyte develops scientific instruments that combine proprietary optics, microfluidics, and artificial intelligence to enable high‑throughput, label‑free single‑cell analysis and sorting using its Ghost Cytometry technology. Its flagship product, VisionSort, commercially launched in June and is an AI‑based dual‑mode fluorescence and morphometric cell sorting platform. Since the summer launch the company has completed deliveries to major pharmaceutical companies and leading research institutions in the U.S. The company plans to use new funding to expand production capacity for VisionSort and accelerate sales across North America, Europe, and Asia. ThinkCyte says it will continue developing complementary technologies and products to broaden the impact of Ghost Cytometry in life sciences. The company was founded in 2016 and has offices in Tokyo and Redwood City, California. ThinkCyte develops life‑science research, diagnostic, and therapeutic platforms built around its proprietary image‑based high‑throughput cell sorting technology, Ghost Cytometry. The company focuses on drug discovery, cell therapy, and clinical diagnostics applications of its image‑based cell analysis and sorting system. ThinkCyte intends to use new funding to accelerate development of its cell‑therapy sorting system, expand clinical diagnostics and drug‑discovery activities, and pursue global business growth. The company was founded in 2016 and is led by CEO Waichiro Katsuda. ThinkCyte is based in Tokyo, Japan, and also maintains offices in San Carlos, California. The recent financing strengthens its balance sheet to support product development and international expansion plans.

• Asuene

  Participated · Series C · Aug 2024

  Asuene is a Tokyo-based sustainability AI company founded by CEO Kohei Nishiwada that serves over 50,000 clients worldwide. Its flagship ASUENE platform supports greenhouse gas measurement, reduction, and reporting, and the company also offers NZero, an AI Energy Optimization Platform, and Carbon EX, an Integrated Carbon Credit AI Platform. The company raised $87M in Series D financing in 2026, bringing its total funding to $161M. Asuene plans to use the new capital to pursue M&A to accelerate business expansion in Japan and internationally, to advance AI and product development, and to launch new businesses. Corporate investors in the round included firms such as DAIKIN and RICOH alongside other domestic and international backers.

• Nature

  Led · Series D · Jun 2024

  Nature develops smart-home IoT products (the Nature Remo series) and a smartphone HEMS (Nature Remo E) and is building an energy-management stack to accelerate renewable adoption. The company aims to construct the Nature DER Platform to optimally control distributed energy resources (DERs) using its smart remotes, HEMS, app, and demand-response know‑how. Nature has sold over 650,000 units of the Nature Remo smart remote and offers multiple Remo models including Nature Remo Lapis, Remo 3, Remo mini 2, and Remo nano. Recent commercial partnerships and pilots include Tokyo Gas (battery utilization / IGNITURE), ENEOS Power (EV optimal charging trial), and au Energy & Life (a “Smart節電 with Nature Green” service using Nature Remo Lapis started June 2024). The company was founded in December 2014 and is headquartered in Yokohama, Kanagawa. Proceeds from the Series D are intended to fund construction of the Nature DER Platform, expand partner-led deployments and device integrations, develop new products, and strengthen hiring.

• Oishii

  Participated · Series B · Feb 2024

  Oishii operates large-scale indoor vertical Smart Farms that combine robotics, automation and Japanese farming techniques to grow pesticide-free, Non-GMO strawberries year-round. Founded in 2016, the company has expanded distribution across 18 U.S. states and launched retail in Toronto as its first international market. Oishii has broadened its product portfolio from ultra-premium Omakase Berries to the Koyo and Nikko Berry lines and introduced new pack sizes and formats with retail prices spanning roughly $4.99 to $15 and premium offerings at higher price points. The company has invested in automation and engineering capability, including the 2025 acquisition of Tortuga AgTech and a strategic partnership with MISUMI Group, and is developing an Open Innovation Center in Tokyo to advance R&D. Financially, Oishii has raised $370 million to date and is using new Series C proceeds to scale production, expand farm infrastructure, integrate more robotics, and develop new product formats.

No current team members are available.